Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Mesoblast Ltd (MSB AU)
Watchlist
43
Analysis
Health Care
•
Australia
Mesoblast Limited provides biomedical services. The Company develops drugs for cardiovascular diseases, oncology, hematology, and spine orthopedic disorders treatment. Mesoblast conducts its business worldwide.
more
Watchlist
Filings
Presentations
Events
Refresh
Exchange Announcement •
01 Jul 2024 13:00
Mesoblast to File BLA for Ryoncil FDA Approval Next Week
Attachment
Exchange Announcement •
03 Jun 2024 07:27
Mesoblast Corporate Presentation at Investor Conference
Attachment
Exchange Announcement •
03 Jun 2024 07:22
Corporate Presentation
Attachment
Exchange Announcement •
10 May 2024 07:22
Appendix 3Y for Eric Rose
Attachment
Exchange Announcement •
03 May 2024 07:49
Appendix 3Y for Eric Rose
Attachment
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.2
x